Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to -$730.1 million.

  • Fortress Biotech's Retained Earnings rose 54.31% to -$730.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$730.1 million, marking a year-over-year increase of 54.31%. This contributed to the annual value of -$740.9 million for FY2024, which is 661.95% down from last year.
  • Latest data reveals that Fortress Biotech reported Retained Earnings of -$730.1 million as of Q3 2025, which was up 54.31% from -$736.0 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Retained Earnings high stood at -$491.6 million for Q1 2021, and its period low was -$751.5 million during Q1 2025.
  • Its 5-year average for Retained Earnings is -$646.3 million, with a median of -$680.5 million in 2023.
  • Its Retained Earnings has fluctuated over the past 5 years, first crashed by 1806.89% in 2022, then soared by 54.31% in 2025.
  • Fortress Biotech's Retained Earnings (Quarter) stood at -$547.5 million in 2021, then decreased by 15.85% to -$634.2 million in 2022, then fell by 9.56% to -$694.9 million in 2023, then fell by 6.62% to -$740.9 million in 2024, then grew by 1.45% to -$730.1 million in 2025.
  • Its last three reported values are -$730.1 million in Q3 2025, -$736.0 million for Q2 2025, and -$751.5 million during Q1 2025.